Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...
Singapore: Research from University of Adelaide have shown that immune cells known as macrophages are critical to fertil...
Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumati...
Singapore: Senior scientists from Australia and China are meeting at the Australian Academy of Science on July 23 and 24...
Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12...
Singapore: CardioCel, a cardiovascular tissue patch to repair heart deformities including repairing and reconstructing h...
Singapore: Australia-based medical device developer Aimedics, in consultation with Therapeutic Goods Administration (TGA...
Singapore: Benitec Biopharma and uniQure, a leader in the field of human gene therapy, announced a non-exclusive cross...
Singapore: The US Patent and Trademark Office (USPTO) has granted Unilife patent for the Unifill ready-to-fill (prefille...
Singapore: Japan-based Fujikura Kasei is going to licence cancer diagnostic antibody midkine (MK) developed by Australia...
China, Japan, India and Singapore are leveraging on genetic technologies to develop molecular diagnostic platform which ...
Singapore: DSM Pharmaceutical, the custom manufacturing and technology business of Royal DSM, has launched its new cGMP ...
Singapore: Australian drug delivery technology company Phosphagenics has appointed US pharmaceutical consulting company,...
Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generi...
Singapore: Living Cell Technologies (LCT) has received ethical approval from the New Zealand Ministry of Health's Healt...
Singapore: TranScrip Partners, a UK-based contract service organization, has appointed Australia-based Dr Glen Pater. D...
Singapore: QRxPharma announced that the company resubmitted its Moxduo New Drug Application (NDA) to the US FDA. As dis...
Singapore: Mayne Pharma Group has announced the launch of Doxycycline Hyclate Delayed-Release tablet in the US through t...
